This mutated p53 protein not only loses the function of its wild-type form to prevent tumorigenesis (loss of function, LOF), but also acquires tumor-promoting activities (gain of function, GOF), such as an increased ability for proliferation, migration, and drug resistance [75]. The gene discussed is TP53; the disease is neoplasm.